[The neurotropic activity of peptide immunomodulators].
Grechko. A T AT
Key Findings
- Thymalin showed a neuromodulating effect in rats comparable to known brain‑active drugs
- It altered the animals’ circadian motor activity and how quickly they stopped investigating new objects
- In the ranking of tested peptides, thymalin was middle‑of‑the‑pack, better than some but weaker than ethymizol and cerebrolysin
Practical Outcomes
- Thymalin may have mild brain‑active properties, but the evidence is limited to animal behavior. Biohackers should treat this as a preliminary clue, not a proven supplement, and wait for human data before adding it to a regimen.
Summary
In a short animal test, the peptide thymalin changed how rats moved and slept, acting like a brain‑boosting drug, though it wasn’t the strongest of the compounds tested. The study only used rats and didn’t give dosing details for people, so the results are a hint, not a recipe.
Abstract
Four-day monitoring using standard methods of studying free group behavior of animals in an "open field" (Opto-Varimex, USA) showed that all the peptide immunomodulators under study possessed a neuromodulating effect comparable with that of known drugs. They change the character of the circadian rhythms of the animals' motor activity and the dynamics of extinction of the orientation-investigation reaction. In comparison with the control the activity of the drugs under study was distributed as follows: ethymizol > cerebrolysin > thymalin > nootropil > thymogen > T-activin > cortexin > dibazol.
Study Information
pubmed
1998